{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:59:30Z","timestamp":1790315970332,"version":"4.1.0"},"reference-count":0,"publisher":"Bentham Science Publishers Ltd.","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["RADDF"],"published-print":{"date-parts":[[2026,9,24]]},"abstract":"<jats:sec>\n                    <jats:title\/>\n                    <jats:p>Lectins are carbohydrate-binding proteins that have emerged as promising candidates for\nvaccine development due to their dual roles as immunomodulatory agents and antigen delivery systems.\nThrough specific interactions with glycans expressed on immune and epithelial cells, lectins can\nenhance antigen uptake, processing, and presentation, modulating innate and adaptive immune responses.\nSeveral lectins have been shown to activate antigen-presenting cells, stimulate cytokine production,\nand promote Th1- or Th2-biased immune responses by recognizing glycosylated receptors,\nincluding Toll-like receptors. These properties make lectins attractive alternatives or complements to\nconventional vaccine adjuvants. This mini-review summarizes recent advances in the application of\nlectins as vaccine adjuvants and delivery platforms. We discuss their mechanisms of action, their contribution\nto innate and mucosal immunity, and their ability to target antigens to specialized cells, such\nas dendritic cells and intestinal M cells. Special emphasis is placed on mucosal vaccination strategies,\nwhere lectins exhibit unique advantages due to their resistance to gastrointestinal degradation, mucoadhesive\nproperties, and ability to facilitate transepithelial transport of antigens. We also highlight potential\nuses of lectin-functionalized Poly(lactic-co-glycolic acid) (PLGA) nanoparticles, which combine\nantigenic protection, targeted delivery, and immunostimulatory activity. In addition, emerging\napproaches employing lectin-based surface display systems in microorganisms are discussed as innovative\nplatforms for antigen presentation and vaccine development. Although several challenges remain\nregarding safety, standardization, and clinical translation, the accumulating evidence indicates\nthat lectins represent versatile tools for increasing vaccine efficacy. A deeper understanding of lectinglycan\ninteractions may support the development of next-generation vaccines capable of inducing robust,\ntargeted, and long-lasting protective immune responses.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.2174\/0126673878465675260827101211","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:22:02Z","timestamp":1790313722000},"source":"Crossref","is-referenced-by-count":0,"title":["Lectins as Adjuvants and Vaccine Delivery Systems: A Mini-Review"],"prefix":"10.2174","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7425-3444","authenticated-orcid":true,"given":"Guilherme Feijo","family":"de Sousa","sequence":"first","affiliation":[{"name":"Bioinformatics and Proteomics Laboratory (BioPro Lab), Technological Development Center, Federal University ofPelotas, Cap\u00e3o do Le\u00e3o, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-2587-7753","authenticated-orcid":true,"given":"Chrystian","family":"Nunes Goncalves","sequence":"additional","affiliation":[{"name":"Bioinformatics and Proteomics Laboratory (BioPro Lab), Technological Development Center, Federal University ofPelotas, Cap\u00e3o do Le\u00e3o, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-6850-9794","authenticated-orcid":true,"given":"Danillo","family":"de Oliveira Della Senta","sequence":"additional","affiliation":[{"name":"Bioinformatics and Proteomics Laboratory (BioPro Lab), Technological Development Center, Federal University ofPelotas, Cap\u00e3o do Le\u00e3o, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8656-4031","authenticated-orcid":true,"given":"Luciano","family":"da Silva Pinto","sequence":"additional","affiliation":[{"name":"Bioinformatics and Proteomics Laboratory (BioPro Lab), Technological Development Center, Federal University ofPelotas, Cap\u00e3o do Le\u00e3o, RS, Brazil"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"965","container-title":["Recent Advances in Drug Delivery and Formulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0126673878465675260827101211","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/258687\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/0126673878465675260827101211","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:22:10Z","timestamp":1790313730000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/258687\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,24]]},"references-count":0,"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/0126673878465675260827101211","relation":{},"ISSN":["2667-3878"],"issn-type":[{"value":"2667-3878","type":"print"}],"subject":[],"published":{"date-parts":[[2026,9,24]]}}}